Safe Wegovy Transition With Clinical Support From £79.99
How To Switch From Mounjaro To Wegovy: Starting Dose Considerations
Understanding how to switch from Mounjaro to Wegovy requires careful attention to the starter dose protocol, regardless of your previous Mounjaro dose level. Wegovy's MHRA-approved dose escalation begins with 0.25mg for weeks 1–4, available at £79.99 from EverydayMeds. This starter approach allows your body to readjust to semaglutide's GLP-1-only mechanism after Mounjaro's dual GIP and GLP-1 pathway. The transition timing typically involves stopping Mounjaro and beginning Wegovy 0.25mg within the same week, though your prescriber will confirm the exact schedule based on your treatment history.
Many patients wonder whether they can skip the starter dose when switching from Mounjaro to Wegovy, particularly if they were on higher Mounjaro doses like 10mg or 15mg. However, the 0.25mg starting protocol remains mandatory for safety reasons, as semaglutide and tirzepatide have different pharmacokinetic profiles despite both targeting weight management. This restart approach minimises potential side effects and ensures optimal tolerance as your system adapts to the new medication. The £79.99 starter dose provides four weeks of treatment, giving adequate time to assess your response before progressing to 0.5mg in weeks 5–8.
Wegovy Starter Pricing And Value When Switching From Mounjaro
The cost consideration when learning how to switch from Mounjaro to Wegovy often centres on the starter dose investment and ongoing treatment expenses. EverydayMeds offers Wegovy 0.25mg starter pens at £79.99, with new customers applying discount code FIRST40 at checkout and returning patients using DOSE25 to reach this final price. Our Intro Duo bundle pairs the starter dose with the next escalation level (0.5mg) for £169.99, providing eight weeks of continuous treatment during your switch period. This bundling approach ensures treatment continuity without multiple ordering requirements during the critical transition phase.
Comparing the switching costs, Wegovy's starter approach requires this initial £79.99 investment regardless of your previous Mounjaro dose level, followed by the standard escalation schedule reaching £209.99 for the 2.4mg maintenance dose from week 17 onwards. The prescription-only medicine status means each dose requires clinical assessment, though our streamlined process typically completes prescriber review within three working days (or 24 hours with express service). This transparent pricing structure helps patients budget effectively for the transition period and ongoing weight management commitment.
Clinical Evidence Supporting Switching From Mounjaro To Wegovy
The clinical foundation for how to switch from Mounjaro to Wegovy rests on Wegovy's comprehensive STEP trial programme, particularly the landmark STEP 1 study published by Wilding et al. in the New England Journal of Medicine, 2021. In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo, demonstrating robust efficacy for the semaglutide approach. The STEP 5 extension data showed sustained weight loss of approximately 15.2% maintained over two years, indicating long-term effectiveness for patients committed to continued treatment.
Patients switching from Mounjaro to Wegovy can reference the SELECT cardiovascular outcomes trial, which demonstrated a 20% reduction in major cardiovascular events (hazard ratio 0.80) in patients with established cardiovascular disease. This evidence supports Wegovy's role beyond weight management, potentially offering cardiovascular protection for appropriate candidates. However, individual results vary considerably, and the decision to switch requires careful discussion with your prescriber regarding your specific medical history, treatment goals, and response to previous therapy.
How Wegovy Works: GLP-1 Mechanism After Mounjaro Switch
Understanding how to switch from Mounjaro to Wegovy involves recognising the mechanistic differences between tirzepatide's dual GIP and GLP-1 agonism versus semaglutide's selective GLP-1 receptor targeting. Wegovy works by mimicking the natural GLP-1 hormone, binding to receptors in the brain's appetite centres to reduce food cravings and promote satiety after smaller meal portions. This prescription-only medicine slows gastric emptying, helping patients feel fuller for longer periods and naturally reducing caloric intake when combined with a reduced-calorie diet and increased physical activity. The once-weekly injection schedule maintains consistent blood levels throughout the week, providing steady appetite control compared to daily interventions. Patients often notice reduced interest in high-calorie foods and decreased portion sizes within the first few weeks of treatment, though individual responses vary significantly.
EverydayMeds Ordering Process For Wegovy Switching
The practical process of how to switch from Mounjaro to Wegovy through EverydayMeds begins with our comprehensive three-minute online clinical assessment, covering your Mounjaro treatment history, current dose, last injection timing, and medical background. Our GPhC-registered clinical team (pharmacy registration #9012878) reviews your assessment alongside the switch protocol, typically completing prescriber approval within three working days, though express 24-hour review is available for urgent treatment continuation needs. Once approved, your Wegovy starter dose ships via next-day delivery using cold-chain temperature-controlled packaging to maintain the medication's integrity. The FlexTouch pen system arrives with complete injection instructions, dose escalation schedule, and direct access to our clinical support team for any switching-related questions. Payment processing includes automatic application of discount codes at checkout, with FIRST40 for new customers and DOSE25 for returning patients.
Storage Advantages When Switching From Mounjaro To Wegovy
A practical benefit when considering how to switch from Mounjaro to Wegovy involves the improved storage flexibility, particularly relevant for patients with active lifestyles or frequent travel commitments. Wegovy maintains stability for six weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit, providing significantly more flexibility for holidays, business travel, or emergency situations. The FlexTouch pen design offers reliable dose delivery throughout the four-week treatment period, with clear dose escalation markings to prevent confusion during the switch transition. Standard storage requires refrigeration at 2–8°C before first use, and the pen should never be frozen or exposed to direct sunlight. Patients switching from Mounjaro to Wegovy often appreciate this storage advantage, especially during the summer months or when travelling to warmer climates where refrigeration access might be limited.
Transition Timeline: Managing Your Switch From Mounjaro To Wegovy
The specific timeline for how to switch from Mounjaro to Wegovy requires coordination between stopping your current tirzepatide treatment and initiating the 0.25mg starter dose, typically managed as a same-week transition to maintain treatment continuity. Most prescribers recommend taking your final Mounjaro injection on your regular schedule, then beginning Wegovy 0.25mg approximately 3–7 days later, though individual timing may vary based on your current dose level and treatment response history. This overlap period allows tirzepatide to clear your system whilst preventing extended gaps in appetite control support.
During weeks 1–4 of switching from Mounjaro to Wegovy, patients often experience readjustment effects as their body adapts to the different receptor targeting profile, potentially including temporary changes in appetite control strength or side effect patterns. The mandatory four-week starter period cannot be abbreviated, even for patients previously tolerating higher Mounjaro doses, as the medications have distinct pharmacological profiles requiring gradual system adaptation. Weeks 5–8 progress to 0.5mg (£94.99), followed by 1mg for weeks 9–12 (£99.99), then 1.7mg for weeks 13–16 (£139.99), reaching the 2.4mg maintenance dose (£209.99) from week 17 onwards.
Complete Your Wegovy Switch With Confidence
Making the decision on how to switch from Mounjaro to Wegovy becomes straightforward with EverydayMeds' comprehensive clinical support and transparent pricing structure, beginning with our £79.99 starter dose covering your first four weeks of treatment. Our GPhC-registered pharmacy (#9012878) ensures full regulatory compliance whilst our clinical team provides personalised guidance throughout your switching journey, from initial assessment through ongoing dose escalations. New customers can apply discount code FIRST40 at checkout, whilst returning patients use DOSE25 to access these competitive prices with next-day delivery and cold-chain protection. The prescription-only medicine status ensures appropriate clinical oversight during your transition, with express review options available for seamless treatment continuation. Visit https://everydaymeds.co.uk/products/wegovy-0-25mg to begin your switching assessment today, supported by our commitment to safe, effective weight management solutions.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
